1/24/25 16:15 | 1/4/24 | KROS | Health | Drug | Pharmaceutical Preparations | Regnante Keith | MA | O | CFO | M.a | 640 | 16.00 | 0 | 40 | | 0 | D | | | | | | | | | | | | | | |
1/24/25 16:15 | 1/4/24 | KROS | Health | Drug | Pharmaceutical Preparations | Regnante Keith | MA | O | CFO | S.a | -1,812 | 45.29 | 0 | -40 | -100 | 0 | D | | | | | | | | | | | | | | |
8/15/24 17:06 | 8/13/24 | KROS | Health | Drug | Pharmaceutical Preparations | Gordon Carl L | MA | D | | S | -11,003 | 44.01 | 0 | -250 | -68 | 120 | I | | | | | | | | | | | | | | |
8/15/24 17:01 | 8/13/24 | KROS | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | D | | S | -11,003 | 44.01 | 0 | -250 | -68 | 120 | I | | | | | | | | | | | | | | |
1/8/24 16:43 | 11/4/23 | KROS | Health | Drug | Pharmaceutical Preparations | Regnante Keith | MA | O | CFO | M.d | 640 | 16.00 | 0 | 40 | | 0 | D | | | | | | | | | | | | | | |
1/8/24 16:43 | 11/4/23 | KROS | Health | Drug | Pharmaceutical Preparations | Regnante Keith | MA | O | CFO | S.d | -1,812 | 45.29 | 0 | -40 | -100 | 0 | D | | | | | | | | | | | | | | |
6/12/23 16:13 | 6/8/23 | KROS | Health | Drug | Pharmaceutical Preparations | Regnante Keith | MA | O | CFO | M.dm | 640 | 16.00 | 0 | 40 | | 0 | D | | | | | | | | | | | | | | |
6/12/23 16:13 | 6/8/23 | KROS | Health | Drug | Pharmaceutical Preparations | Regnante Keith | MA | O | CFO | S.dm | -1,864 | 46.61 | 0 | -40 | -100 | 0 | D | | | | | | | | | | | | | | |
4/11/23 16:05 | 4/8/23 | KROS | Health | Drug | Pharmaceutical Preparations | Seehra Jasbir | MA | DO | CEO | M.d | 2 | 0.4800 | 0 | 4 | 2 | 253 | D | | | | | | | | | | | | | | |
1/20/23 16:32 | 4/13/20 | KROS | Health | Drug | Pharmaceutical Preparations | Knowles Julius | MA | D | | P | 25 | 20.98 | 0 | 1 | 0 | 575 | D | | | | | | | | | | | | | | |
7/19/22 16:40 | 7/15/22 | KROS | Health | Drug | Pharmaceutical Preparations | Lachey Jennifer | MA | O | Chief Sc | M.d | 14 | 0.3000 | 0 | 46 | 94 | 95 | D | | | | | | | | | | | | | | |
7/19/22 16:40 | 7/15/22 | KROS | Health | Drug | Pharmaceutical Preparations | Lachey Jennifer | MA | O | Chief Sc | S.d | -1,381 | 30.00 | 0 | -46 | -33 | 95 | D | | | | | | | | | | | | | | |
7/15/22 16:40 | 7/13/22 | KROS | Health | Drug | Pharmaceutical Preparations | Lachey Jennifer | MA | O | Chief Sc | M.d | 1 | 0.3000 | 0 | 2 | 2 | 95 | D | | | | | | | | | | | | | | |
7/15/22 16:40 | 7/13/22 | KROS | Health | Drug | Pharmaceutical Preparations | Lachey Jennifer | MA | O | Chief Sc | S.d | -57 | 30.00 | 0 | -2 | -2 | 95 | D | | | | | | | | | | | | | | |
6/14/22 18:57 | 6/14/22 | KROS | Health | Drug | Pharmaceutical Preparations | Lachey Jennifer | MA | O | Chief Sc | M.d | 3 | 0.3000 | 0 | 9 | 11 | 95 | D | | | | | | | | | | | | | | |
6/10/22 16:12 | 6/9/22 | KROS | Health | Drug | Pharmaceutical Preparations | Seehra Jasbir | MA | DO | CEO | M.d | 2 | 0.3000 | 0 | 5 | 2 | 249 | D | | | | | | | | | | | | | | |
5/13/22 16:37 | 5/11/22 | KROS | Health | Drug | Pharmaceutical Preparations | Lachey Jennifer | MA | O | Chief Sc | M.d | 2 | 0.3000 | 0 | 5 | 7 | 86 | D | | | | | | | | | | | | | | |
5/13/22 16:37 | 5/11/22 | KROS | Health | Drug | Pharmaceutical Preparations | Lachey Jennifer | MA | O | Chief Sc | S.d | -222 | 41.90 | 0 | -5 | -6 | 86 | D | | | | | | | | | | | | | | |